SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All alpha proteins (14657)
(-)
Fold: HD-domain/PDEase-like (204)
(-)
Superfamily: HD-domain/PDEase-like (204)
(-)
Family: automated matches (60)
(-)
Protein domain: automated matches (60)
(-)
Human (Homo sapiens) [TaxId: 9606] (44)
1ZKLA:MULTIPLE DETERMINANTS FOR INHIBITOR SELECTIVITY OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES
2OUNA:; B:CRYSTAL STRUCTURE OF PDE10A2 IN COMPLEX WITH AMP
2OUPA:; B:CRYSTAL STRUCTURE OF PDE10A
2OUQA:; B:CRYSTAL STRUCTURE OF PDE10A2 IN COMPLEX WITH GMP
2OURA:; B:CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A IN COMPLEX WITH CAMP
2OUSA:; B:CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A
2OUUA:; B:CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A IN COMPLEX WITH CGMP
2OUVA:; B:CRYSTAL STRUCTURE OF PDE10A2 MUTANT OF D564N
2OUYA:; B:CRYSTAL STRUCTURE OF PDE10A2 MUTANT D564A IN COMPLEX WITH CAMP.
2WEYA:; B:HUMAN PDE-PAPAVERINE COMPLEX OBTAINED BY LIGAND SOAKING OF CROSS-LINKED PROTEIN CRYSTALS
2Y0JA:; B:TRIAZOLOQUINAZOLINES AS A NOVEL CLASS OF PHOSPHODIESTERASE 10A (PDE10A) INHIBITORS, PART 2, LEAD-OPTIMISATION.
3ECMA:CRYSTAL STRUCTURE OF THE UNLIGANDED PDE8A CATALYTIC DOMAIN
3ECNA:; B:CRYSTAL STRUCTURE OF PDE8A CATALYTIC DOMAIN IN COMPLEX WITH IBMX
3G3NA:PDE7A CATALYTIC DOMAIN IN COMPLEX WITH 3-(2,6-DIFLUOROPHENYL)-2-(METHYLTHIO)QUINAZOLIN-4(3H)-ONE
3SN7A:; B:HIGHLY POTENT, SELECTIVE, AND ORALLY ACTIVE PHOSPHODIESTARASE 10A INHIBITORS
3SNIA:; B:HIGHLY POTENT, SELECTIVE, AND ORALLY ACTIVE PHOSPHODIESTARASE 10A INHIBITORS
3SNLA:; B:HIGHLY POTENT, SELECTIVE, AND ORALLY ACTIVE PHOSPHODIESTARASE 10A INHIBITORS
3UI7A:; B:DISCOVERY OF ORALLY ACTIVE PYRAZOLOQUINOLINE AS A POTENT PDE10 INHIBITOR FOR THE MANAGEMENT OF SCHIZOPHRENIA
3UUOA:; B:THE DISCOVERY OF POTENT, SELECTIVITY, AND ORALLY BIOAVAILABLE PYROZOLOQUINOLINES AS PDE10 INHIBITORS FOR THE TREATMENT OF SCHIZOPHRENIA
3WI2A:; B:CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH INHIBITOR
4AELA:; B:PDE10A IN COMPLEX WITH THE INHIBITOR AZ5
4AJDA:; D:IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT INHIBITORS
4AJFA:; D:IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT INHIBITORS
4AJGA:; D:IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT INHIBITORS
4AJMA:; D:DEVELOPMENT OF A PLATE-BASED OPTICAL BIOSENSOR METHODOLOGY TO IDENTIFY PDE10 FRAGMENT INHIBITORS
4BBXB:DISCOVERY OF A POTENT, SELECTIVE AND ORALLY ACTIVE PDE10A INHIBITOR FOR THE TREATMENT OF SCHIZOPHRENIA
4DDLA:; B:PDE10A CRYSTAL STRUCTURE COMPLEXED WITH NOVEL INHIBITOR
4DFFA:; B:THE SAR DEVELOPMENT OF DIHYDROIMIDAZOISOQUINOLINE DERIVATIVES AS PHOSPHODIESTERASE 10A INHIBITORS FOR THE TREATMENT OF SCHIZOPHRENIA
4FCBA:; B:POTENT AND SELECTIVE PHOSPHODIESTERASE 10A INHIBITORS
4FCDA:; B:POTENT AND SELECTIVE PHOSPHODIESTERASE 10A INHIBITORS
4HEUA:; B:CRYSTAL STRUCTURE OF PDE10A WITH A BIARYL ETHER INHIBITOR ((1-(3-(4-((1H-BENZO[D]IMIDAZOL-2-YL)AMINO)PHENOXY)PYRIDIN-2-YL)PIPERIDIN-4-YL)METHANOL)
4HF4A:; B:CRYSTAL STRUCTURE OF PDE10A WITH A BIARYL ETHER INHIBITOR (1-(1-(3-(4-(BENZO[D]THIAZOL-2-YLAMINO)PHENOXY)PYRAZIN-2-YL)PIPERIDIN-4-YL) ETHANOL)
4LKQA:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT017
4LLJA:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT214
4LLKA:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT217
4LLPA:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT401
4LLXA:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT434
4LM0A:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT448
4LM1A:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT450
4LM2A:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT462
4LM3A:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT464
4LM4A:; B:CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT902
4MUWA:; B:CRYSTAL STRUCTURE OF PDE10A WITH NOVEL KETO-BENZIMIDAZOLE INHIBITOR
4MVHA:; B:CRYSTAL STRUCTURE OF PDE10A WITH NOVEL KETO-BENZIMIDAZOLE INHIBITOR
(-)
Leishmania major [TaxId: 5664] (1)
2R8QA:; B:STRUCTURE OF LMJPDEB1 IN COMPLEX WITH IBMX
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (11)
2O8HA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT PHOSPHODIESTERASE 10A
2OVVA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT PHOSPHODIESTERASE 10A
2OVYA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT PHOSPHODIESTERASE 10A
3HQWA:DISCOVERY OF NOVEL INHIBITORS OF PDE10A
3HQYA:DISCOVERY OF NOVEL INHIBITORS OF PDE10A
3HQZA:DISCOVERY OF NOVEL INHIBITORS OF PDE10A
3HR1A:DISCOVERY OF NOVEL INHIBITORS OF PDE10A
3LXGA:CRYSTAL STRUCTURE OF RAT PHOSPHODIESTERASE 10A IN COMPLEX WITH LIGAND WEB-3
3QPNA:STRUCTURE OF PDE10-INHIBITOR COMPLEX
3QPOA:STRUCTURE OF PDE10-INHIBITOR COMPLEX
3QPPA:STRUCTURE OF PDE10-INHIBITOR COMPLEX
(-)
Shewanella amazonensis [TaxId: 326297] (1)
3M1TA:CRYSTAL STRUCTURE OF PUTATIVE PHOSPHOHYDROLASE (YP_929327.1) FROM SHEWANELLA AMAZONENSIS SB2B AT 1.62 A RESOLUTION
(-)
Trypanosoma cruzi [TaxId: 5693] (2)
3V93A:; B:; C:; D:; E:; F:; G:; H:UNLIGANDED STRUCTURE OF TCRPDEC1 CATALYTIC DOMAIN
3V94A:; C:; D:; E:; F:; G:; H:; B:TCRPDEC1 CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR WYQ16
(-)
Trypanosome (Trypanosoma brucei) [TaxId: 5691] (1)
4I15A:; B:CRYSTAL STRUCTURE OF TBRPDEB1
(-)
Family: HD domain (20)
(-)
Protein domain: 5'-nucleotidase YfbR (3)
(-)
Escherichia coli [TaxId: 562] (3)
2PAQA:; B:CRYSTAL STRUCTURE OF THE 5'-DEOXYNUCLEOTIDASE YFBR
2PARA:; B:CRYSTAL STRUCTURE OF THE 5'-DEOXYNUCLEOTIDASE YFBR MUTANT E72A COMPLEXED WITH CO(2+) AND TMP
2PAUA:; B:CRYSTAL STRUCTURE OF THE 5'-DEOXYNUCLEOTIDASE YFBR MUTANT E72A COMPLEXED WITH CO(2+) AND DAMP
(-)
Protein domain: automated matches (2)
(-)
Aquifex aeolicus [TaxId: 63363] (1)
2HEKB:CRYSTAL STRUCTURE OF O67745, A HYPOTHETICAL PROTEIN FROM AQUIFEX AEOLICUS AT 2.0 A RESOLUTION.
(-)
Pyrococcus horikoshii [TaxId: 70601] (1)
2CQZA:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF PH0347 PROTEIN FROM PYROCOCCUS HORIKOSHII OT3
(-)
Protein domain: Hypothetical protein AF1432 (2)
(-)
Archaeoglobus fulgidus [TaxId: 2234] (2)
1YNBA:7-173; B:; C:CRYSTAL STRUCTURE OF GENOMICS APC5600
1YOYA:7-172PREDICTED CODING REGION AF1432 FROM ARCHAEOGLOBUS FULGIDUS
(-)
Protein domain: Hypothetical protein aq_1910 (1)
(-)
Aquifex aeolicus [TaxId: 63363] (1)
2HEKA:1-369CRYSTAL STRUCTURE OF O67745, A HYPOTHETICAL PROTEIN FROM AQUIFEX AEOLICUS AT 2.0 A RESOLUTION.
(-)
Protein domain: Hypothetical protein Atu1052 (1)
(-)
Agrobacterium tumefaciens [TaxId: 358] (1)
2GZ4A:6-205; B:; C:; D:1.5 A CRYSTAL STRUCTURE OF A PROTEIN OF UNKNOWN FUNCTION ATU1052 FROM AGROBACTERIUM TUMEFACIENS
(-)
Protein domain: Hypothetical protein EF1143 (3)
(-)
Enterococcus faecalis [TaxId: 1351] (3)
2O6IA:1-453; B:STRUCTURE OF AN ENTEROCOCCUS FAECALIS HD DOMAIN PHOSPHOHYDROLASE
3IRHA:; B:; C:; D:STRUCTURE OF AN ENTEROCOCCUS FAECALIS HD-DOMAIN PROTEIN COMPLEXED WITH DGTP AND DATP
4LRLA:; B:; C:; D:STRUCTURE OF AN ENTEROCOCCUS FAECALIS HD-DOMAIN PROTEIN COMPLEXED WITH DGTP AND DTTP
(-)
Protein domain: Oxetanocin-like protein PF0395 (1)
(-)
Pyrococcus furiosus [TaxId: 2261] (1)
1XX7A:; B:; C:; D:; E:; F:CONSERVED HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU-403030-001
(-)
Protein domain: Predicted hydrolase mes0020 (1)
(-)
Uncultured thermotogales bacterium [TaxId: 221214] (1)
2PQ7A:1-217CRYSTAL STRUCTURE OF PREDICTED HD SUPERFAMILY HYDROLASE (104161995) FROM UNCULTURED THERMOTOGALES BACTERIUM AT 1.45 A RESOLUTION
(-)
Protein domain: Stringent response-like protein RelA N-terminal domain (1)
(-)
Streptococcus equisimilis [TaxId: 119602] (1)
1VJ7A:5-196; B:5-196CRYSTAL STRUCTURE OF THE BIFUNCTIONAL CATALYTIC FRAGMENT OF RELSEQ, THE RELA/SPOT HOMOLOG FROM STREPTOCOCCUS EQUISIMILIS.
(-)
Protein domain: Uncharacterized protein BH2835 (1)
(-)
Bacillus halodurans [TaxId: 86665] (1)
3DTOA:2-213; B:2-213; C:2-213; D:2-213CRYSTAL STRUCTURE OF THE METAL-DEPENDENT HD DOMAIN-CONTAINING HYDROLASE BH2835 FROM BACILLUS HALODURANS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BHR130.
(-)
Protein domain: Uncharacterized protein BT9727_1981 (1)
(-)
Bacillus thuringiensis [TaxId: 1428] (1)
3DJBA:2-214; B:CRYSTAL STRUCTURE OF A HD-SUPERFAMILY HYDROLASE (BT9727_1981) FROM BACILLUS THURINGIENSIS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BUR114
(-)
Protein domain: Uncharacterized protein Lin1889 (1)
(-)
Listeria innocua [TaxId: 1642] (1)
3B57A:1-201CRYSTAL STRUCTURE OF THE LIN1889 PROTEIN (Q92AN1) FROM LISTERIA INNOCUA. NORTHEAST STRUCTURAL CONSORTIUM TARGET LKR65
(-)
Protein domain: Uncharacterized protein LP2664 (1)
(-)
Lactobacillus plantarum [TaxId: 1590] (1)
2PJQA:1-215; B:; C:; D:CRYSTAL STRUCTURE OF Q88U62_LACPL FROM LACTOBACILLUS PLANTARUM. NORTHEAST STRUCTURAL GENOMICS TARGET LPR71
(-)
Protein domain: Uncharacterized protein SE1688 (1)
(-)
Staphylococcus epidermidis [TaxId: 1282] (1)
2QGSA:1-216; B:CRYSTAL STRUCTURE OF SE1688 PROTEIN FROM STAPHYLOCOCCUS EPIDERMIDIS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SER89
(-)
Family: MioX-like (3)
(-)
Protein domain: Myo-inositol oxygenase MioX (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2IBNA:37-285; B:CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL OXYGENASE (MIOX)
(-)
Mouse (Mus musculus) [TaxId: 10090] (2)
2HUOA:28-285CRYSTAL STRUCTURE OF MOUSE MYO-INOSITOL OXYGENASE IN COMPLEX WITH SUBSTRATE
3BXDA:CRYSTAL STRUCTURE OF MOUSE MYO-INOSITOL OXYGENASE (RE-REFINED)
(-)
Family: modified HD domain (1)
(-)
Protein domain: Hypothetical protein Cj0248 (1)
(-)
Campylobacter jejuni [TaxId: 197] (1)
1VQRA:; B:; C:; D:CRYSTAL STRUCTURE OF A VIRULENCE FACTOR (CJ0248) FROM CAMPYLOBACTER JEJUNI SUBSP. JEJUNI AT 2.25 A RESOLUTION
(-)
Family: PDEase (118)
(-)
Protein domain: automated matches (21)
(-)
Human (Homo sapiens) [TaxId: 9606] (21)
2QYKA:; B:CRYSTAL STRUCTURE OF PDE4A10 IN COMPLEX WITH INHIBITOR NPV
2QYMA:CRYSTAL STRUCTURE OF UNLIGANDED PDE4C2
2YY2A:; B:CRYSTAL STRUCTURE OF THE HUMAN PHOSPHODIESTERASE 9A CATALYTIC DOMAIN COMPLEXED WITH IBMX
3HC8A:INVESTIGATION OF AMINOPYRIDIOPYRAZINONES AS PDE5 INHIBITORS: EVALUATION OF MODIFICATIONS TO THE CENTRAL RING SYSTEM.
3HDZA:IDENTIFICATION, SYNTHESIS, AND SAR OF AMINO SUBSTITUTED PYRIDO[3, 2B]PRYAZIONES AS POTENT AND SELECTIVE PDE5 INHIBITORS
3I8VA:; B:CRYSTAL STRUCTURE OF HUMAN PDE4A WITH 4-(3-BUTOXY-4-METHOXYPHENYL) METHYL-2-IMIDAZOLIDONE
3JWQA:; B:; C:; D:CRYSTAL STRUCTURE OF CHIMERIC PDE5/PDE6 CATALYTIC DOMAIN COMPLEXED WITH SILDENAFIL
3JWRB:CRYSTAL STRUCTURE OF CHIMERIC PDE5/PDE6 CATALYTIC DOMAIN COMPLEXED WITH 3-ISOBUTYL-1-METHYLXANTHINE (IBMX) AND PDE6 GAMMA-SUBUNIT INHIBITORY PEPTIDE 70-87.
3O0JA:PDE4B IN COMPLEX WITH LIGAND AN2898
3QI3A:; B:CRYSTAL STRUCTURE OF PDE9A(Q453E) IN COMPLEX WITH INHIBITOR BAY73-6691
3SHYA:CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS
3SHZA:CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS
3SIEA:; B:CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS
3TSE  [entry was replaced by entry 4OEX without any SCOP domain information]
3TSF  [entry was replaced by entry 4OEW without any SCOP domain information]
3TVXA:; B:THE STRUCTURE OF PDE4A WITH PENTOXIFYLLINE AT 2.84A RESOLUTION
4G2WA:CRYSTAL STRUCTURE OF PDE5A IN COMPLEX WITH ITS INHIBITOR
4G2YA:CRYSTAL STRUCTURE OF PDE5A COMPLEXED WITH ITS INHIBITOR
4I9ZA:CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS
4IA0A:CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS
4MYQA:SELECTIVE INHIBITION OF THE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B WITH A-33
(-)
Protein domain: Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1TAZA:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 1B
(-)
Protein domain: Catalytic domain of cyclic nucleotide phosphodiesterase 4b2b (28)
(-)
Human (Homo sapiens) [TaxId: 9606] (28)
1F0JA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B
1RO6A:; B:CRYSTAL STRUCTURE OF PDE4B2B COMPLEXED WITH ROLIPRAM (R & S)
1RO9A:; B:CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-BR-AMP
1RORA:; B:CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP
1TB5A:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH AMP
1XLXA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH CILOMILAST
1XLZA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH FILAMINAST
1XM4A:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH PICLAMILAST
1XM6A:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-MESOPRAM
1XMUA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH ROFLUMILAST
1XMYA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-ROLIPRAM
1XN0A:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R,S)-ROLIPRAM
1XOSA:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH SILDENAFIL
1XOTA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH VARDENAFIL
1Y2HA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 1-(2-CHLORO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1Y2JA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
2QYLA:CRYSTAL STRUCTURE OF PDE4B2B IN COMPLEX WITH INHIBITOR NPV
3D3PA:CRYSTAL STRUCTURE OF PDE4B CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIDINE INHIBITOR
3FRGA:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B IN COMPLEX WITH A QUINOLINE INHIBITOR
3GWTA:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B IN COMPLEX WITH A QUINOLINE INHIBITOR
3HMVA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B IN COMPLEX WITH A TETRAHYDROBENZOTHIOPHENE INHIBITOR
3KKTA:; B:CRYSTAL STRUCTURE OF HUMAN PDE4B WITH 5-[3-[(1S,2S,4R)-BICYCLO[2.2.1]HEPT-2-YLOXY]-4-METHOXYP HENYL]TETRAHYDRO-2(1H)-PYRIMIDINONE REVEALS ORDERING OF THE C-TERMINAL HELIX RESIDUES 502-509.
3LY2A:; B:; C:; D:; E:; F:; G:; H:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH A COUMARIN-BASED INHIBITOR
3O56A:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B IN COMPLEX WITH A 5-HETEROCYCLE PYRAZOLOPYRIDINE INHIBITOR
3O57A:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B IN COMPLEX WITH A 5-HETEROCYCLE PYRAZOLOPYRIDINE INHIBITOR
3W5EA:; B:CRYSTAL STRUCTURE OF PHOSPHODIESTERASE 4B IN COMPLEX WITH COMPOUND 31E
3WD9A:; B:CRYSTAL STRUCTURE OF PHOSPHODIESTERASE 4B IN COMPLEX WITH COMPOUND 10F
4KP6A:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4B (PDE4B) IN COMPLEX WITH A [1,3,5]TRIAZINE DERIVATIVE
(-)
Protein domain: Catalytic domain of cyclic nucleotide phosphodiesterase pde4d (33)
(-)
Human (Homo sapiens) [TaxId: 9606] (33)
1MKDA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:CRYSTAL STRUCTURE OF PDE4D CATALYTIC DOMAIN AND ZARDAVERINE COMPLEX
1OYNA:; B:; C:; D:CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH (R,S)-ROLIPRAM
1PTWA:; B:; C:; D:THE CRYSTAL STRUCTURE OF AMP-BOUND PDE4 SUGGESTS A MECHANISM FOR PHOSPHODIESTERASE CATALYSIS
1Q9MA:; B:; C:; D:THREE DIMENSIONAL STRUCTURES OF PDE4D IN COMPLEX WITH ROLIPRAMS AND IMPLICATION ON INHIBITOR SELECTIVITY
1TB7A:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH AMP
1TBBA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROLIPRAM
1XOMA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH CILOMILAST
1XONA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH PICLAMILAST
1XOQA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROFLUMILAST
1XORA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ZARDAVERINE
1Y2BA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1Y2CA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1Y2DA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-METHOXY-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1Y2EA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-AMINO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1Y2KA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1ZKNA:; B:; C:; D:STRUCTURE OF PDE4D2-IBMX
2FM0A:; B:; C:; D:CRYSTAL STRUCTURE OF PDE4D IN COMPLEX WITH L-869298
2FM5A:; B:; C:; D:CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH INHIBITOR L-869299
2PW3A:; B:STRUCTURE OF THE PDE4D-CAMP COMPLEX
2QYNA:; B:CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH INHIBITOR NPV
3G4IA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D WITH D155871
3G4KA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D WITH ROLIPRAM
3G4LA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D WITH ROFLUMILAST
3G58A:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D WITH D155988/PMNPQ
3IADA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D WITH BOUND ALLOSTERIC MODULATOR
3IAKA:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D (PDE4D) WITH PAPAVERINE.
3K4SA:THE STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PDE4D WITH 4-(3-BUTOXY-4-METHOXYPHENYL)METHYL-2-IMIDAZOLIDONE
3SL3A:; B:; C:; D:CRYSTAL STRUCTURE OF THE APO FORM OF THE CATALYTIC DOMAIN OF PDE4D2
3SL4A:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH COMPOUND 10D
3SL5A:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 COMPLEXED WITH COMPOUND 10D
3SL6A:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH COMPOUND 12C
3SL8A:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH COMPOUND 10O
3V9BA:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH (S)-N-(3-{1-[1-(3-CYCLOPROPYLMETHOXY-4-DIFLUOROMETHOXYPHENYL)-2-(1-OXYPYRIDIN-4-YL)-ETHYL]-1H-PYRAZL-3-YL}PHENYL)ACETAMIDE
(-)
Protein domain: cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1SO2A:; B:; C:; D:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH A DIHYDROPYRIDAZINE INHIBITOR
1SOJA:; G:; H:; I:; J:; K:; L:; B:; C:; D:; E:; F:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH IBMX
(-)
Protein domain: cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx (17)
(-)
Human (Homo sapiens) [TaxId: 9606] (17)
1RKPA:CRYSTAL STRUCTURE OF PDE5A1-IBMX
1T9RA:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A
1T9SA:; B:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH GMP
1TBFA:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH SILDENAFIL
1UDTA:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH SILDENAFIL(VIAGRA)
1UDUA:; B:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH TADALAFIL(CIALIS)
1UHOA:CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH VARDENAFIL(LEVITRA)
1XOZA:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH TADALAFIL
1XP0A:CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH VARDENAFIL
2CHMA:537-858CRYSTAL STRUCTURE OF N2 SUBSTITUTED PYRAZOLO PYRIMIDINONES-A FLIPPED BINDING MODE IN PDE5
2H40A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF UNLIGANDED PDE5
2H42A:; B:; C:CRYSTAL STRUCTURE OF PDE5 IN COMPLEX WITH SILDENAFIL
2H44A:CRYSTAL STRUCTURE OF PDE5A1 IN COMPLEX WITH ICARISID II
3B2RA:; B:CRYSTAL STRUCTURE OF PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH VARDENAFIL
3BJCA:CRYSTAL STRUCTURE OF THE PDE5A CATALYTIC DOMAIN IN COMPLEX WITH A NOVEL INHIBITOR
3TGEA:A NOVEL SERIES OF POTENT AND SELECTIVE PDE5 INHIBITOR1
3TGGA:A NOVEL SERIES OF POTENT AND SELECTIVE PDE5 INHIBITOR2
(-)
Protein domain: High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A (16)
(-)
Human (Homo sapiens) [TaxId: 9606] (16)
2HD1A:; B:CRYSTAL STRUCTURE OF PDE9 IN COMPLEX WITH IBMX
3DY8A:; B:HUMAN PHOSPHODIESTERASE 9 IN COMPLEX WITH PRODUCT 5'-GMP (E+P COMPLEX)
3DYLA:; B:HUMAN PHOSPHDIESTERASE 9 SUBSTRATE COMPLEX (ES COMPLEX)
3DYNA:; B:HUMAN PHOSPHODIESTRASE 9 IN COMPLEX WITH CGMP (ZN INHIBITED)
3DYQA:; B:HUMAN PHOSPHODIESTRASE 9 (INHIBITED BY OMITTING DIVALENT CATION) IN COMPLEX WITH CGMP
3DYSA:; B:HUMAN PHOSPHODIESTRASE-5'GMP COMPLEX (EP), PRODUCED BY SOAKING WITH 20MM CGMP+20 MM MNCL2+20 MM MGCL2 FOR 2 HOURS, AND FLASH-COOLED TO LIQUID NITROGEN TEMPERATURE WHEN SUBSTRATE WAS STILL ABUDANT.
3JSIA:; B:HUMAN PHOSPHODIESTERASE 9 IN COMPLEX WITH INHIBITOR
3JSWA:; B:HUMAN PDE9 IN COMPLEX WITH SELECTIVE INHIBITOR
3K3EA:; B:CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH (R)-BAY73-6691
3K3HA:; B:CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH (S)-BAY73-6691
3N3ZA:; B:CRYSTAL STRUCTURE OF PDE9A (E406A) MUTANT IN COMPLEX WITH IBMX
3QI4A:; B:CRYSTAL STRUCTURE OF PDE9A(Q453E) IN COMPLEX WITH IBMX
4E90A:; B:HUMAN PHOSPHODIESTERASE 9 IN COMPLEX WITH INHIBITORS
4G2JA:; B:HUMAN PDE9 IN COMPLEX WITH SELECTIVE COMPOUND
4G2LA:; B:HUMAN PDE9 IN COMPLEX WITH SELECTIVE COMPOUND
4GH6A:; B:CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR 28
(-)
Family: Ppx associated domain (2)
(-)
Protein domain: Exopolyphosphatase Ppx C-terminal domain (2)
(-)
Escherichia coli [TaxId: 562] (2)
1U6ZA:313-509; B:313-511STRUCTURE OF AN E. COLI EXOPOLYPHOSPHATASE: INSIGHT INTO THE PROCESSIVE HYDROLYSIS OF POLYPHOSPHATE AND ITS REGULATION
2FLOA:313-506; B:313-506; C:313-506; D:313-506CRYSTAL STRUCTURE OF EXOPOLYPHOSPHATASE (PPX) FROM E. COLI O157:H7